Alevtina I. Zakharova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alevtina I. Zakharova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy V. Cherkashin
Kirov Military Medical Academy
3 shared publications - Aleksey D. Sobolev
S.M. Kirov Military Medical Academy; Saint Petersburg, Russian Federation
2 shared publications - Natalia V. Sharova
S.M. Kirov Military Medical Academy; Saint Petersburg, Russian Federation
2 shared publications - Semyon V. Efimov
Kirov Military Medical Academy
2 shared publications - Dmitriy S. Bogdanov
Kirov Military Medical Academy
1 shared publication - Konstantin N. Tkachenko
Kirov Military Medical Academy
1 shared publication
Latest Publications
- 1 January 2026
- Published by NP Rusmedical Group in Therapist’s Bulletin
The significance of positional changes in spirometric parameters in unilateral diaphragm dysfunction
Aim. To evaluate the diagnostic significance of positional changes in the vital capacity of the lungs (ΔVC) and forced vital capacity of the lungs (ΔFVC) in the verification of unilateral diaphragm dysfunction, confirmed by radiographic data and ultrasound examination results. Design. Comparative observational prospective study Materials and methods. The study was conducted at the Naval Therapy Clinic of the S.M. Kirov Military Medical Academy from March 2021 to January 2025. The study group consisted of 44 patients with medical conditions complicated by unilateral diaphragmatic dysfunction: 12 with complete diaphragmatic dysfunction and 32 with partial diaphragmatic dysfunction. The control group included 20 patients with comparable conditions and no signs of respiratory muscle damage. According to the developed algorithm, all participants underwent a comprehensive examination, including chest X-ray and computed tomography, diaphragm ultrasound, and spirometry. Baseline lung volumes and their positional changes were assessed: ΔVC (%), ΔFVC (%), and forced expiratory volume in the first second (ΔFEV1, %). Results. In case of complete diaphragm dysfunction, a decrease in VCF to 66.0 [58.6; 85.9] % (FVC to 73.5 [63.4; 87.3] %) and a positional decrease in ΔVC% by –16.5 [–25.1; –9.4] % (ΔFVC% by –11.0 [–25.4; –6.3] %) were detected. In case of partial diaphragm dysfunction, the figures were statistically significantly higher: VCF was 80.5 [75.5; 91.2] % (FVC — 76.0 [72.0; 88.4] %) and a positional decrease in ΔVC% by –5.0 [–9.5; –0.4] % (ΔFVC% by –9.7 [–13.0; –5.6] %). In 12 patients with unilateral complete dysfunction, ultrasound examination revealed a combined decrease in diaphragmatic excursion and fractional thickening to 17.0% on the affected side. A statistically significant negative correlation of moderate strength (p = 0.028 and p = 0.04) was established between ΔVC (ΔFVC) and fractional thickening, confirming the involvement of the diaphragm in the genesis of positional changes. The results of dynamic observation indicate the feasibility of individualized assessment of spirometric and positional parameters (ΔVC, ΔFVC, ΔFEV1) for monitoring the functional status of these patients. Conclusion. A positional decrease in the indicators by more than 15%, combined with a decrease in baseline VC and FVC values, can be considered as a diagnostic criterion for unilateral complete diaphragmatic dysfunction. Furthermore, identifying a group of patients with partial diaphragmatic dysfunction allows for a more precise characterization of functional impairment, even in mild cases. In cases where the positional decrease in ΔVC and ΔFVC ranges from 10 to 15%, confirmation of the diagnosis by ultrasound is mandatory. A comprehensive assessment of positional changes in lung volumes and ΔVC and ΔFVC indicators is useful for monitoring the functional status of patients with unilateral diaphragmatic dysfunction during treatment and follow-up. Keywords: unilateral complete dysfunction of the diaphragm, unilateral partial dysfunction of the diaphragm, positional changes, ΔVC, ΔFVC, fractional thickening of the diaphragm.
- 1 January 2026
- Published by NP Rusmedical Group in Therapist’s Bulletin
The significance of positional changes in spirometric parameters in unilateral diaphragm dysfunction
Aim. To evaluate the diagnostic significance of positional changes in the vital capacity of the lungs (ΔVC) and forced vital capacity of the lungs (ΔFVC) in the verification of unilateral diaphragm dysfunction, confirmed by radiographic data and ultrasound examination results. Design. Comparative observational prospective study Materials and methods. The study was conducted at the Naval Therapy Clinic of the S.M. Kirov Military Medical Academy from March 2021 to January 2025. The study group consisted of 44 patients with medical conditions complicated by unilateral diaphragmatic dysfunction: 12 with complete diaphragmatic dysfunction and 32 with partial diaphragmatic dysfunction. The control group included 20 patients with comparable conditions and no signs of respiratory muscle damage. According to the developed algorithm, all participants underwent a comprehensive examination, including chest X-ray and computed tomography, diaphragm ultrasound, and spirometry. Baseline lung volumes and their positional changes were assessed: ΔVC (%), ΔFVC (%), and forced expiratory volume in the first second (ΔFEV1, %). Results. In case of complete diaphragm dysfunction, a decrease in VCF to 66.0 [58.6; 85.9] % (FVC to 73.5 [63.4; 87.3] %) and a positional decrease in ΔVC% by –16.5 [–25.1; –9.4] % (ΔFVC% by –11.0 [–25.4; –6.3] %) were detected. In case of partial diaphragm dysfunction, the figures were statistically significantly higher: VCF was 80.5 [75.5; 91.2] % (FVC — 76.0 [72.0; 88.4] %) and a positional decrease in ΔVC% by –5.0 [–9.5; –0.4] % (ΔFVC% by –9.7 [–13.0; –5.6] %). In 12 patients with unilateral complete dysfunction, ultrasound examination revealed a combined decrease in diaphragmatic excursion and fractional thickening to 17.0% on the affected side. A statistically significant negative correlation of moderate strength (p = 0.028 and p = 0.04) was established between ΔVC (ΔFVC) and fractional thickening, confirming the involvement of the diaphragm in the genesis of positional changes. The results of dynamic observation indicate the feasibility of individualized assessment of spirometric and positional parameters (ΔVC, ΔFVC, ΔFEV1) for monitoring the functional status of these patients. Conclusion. A positional decrease in the indicators by more than 15%, combined with a decrease in baseline VC and FVC values, can be considered as a diagnostic criterion for unilateral complete diaphragmatic dysfunction. Furthermore, identifying a group of patients with partial diaphragmatic dysfunction allows for a more precise characterization of functional impairment, even in mild cases. In cases where the positional decrease in ΔVC and ΔFVC ranges from 10 to 15%, confirmation of the diagnosis by ultrasound is mandatory. A comprehensive assessment of positional changes in lung volumes and ΔVC and ΔFVC indicators is useful for monitoring the functional status of patients with unilateral diaphragmatic dysfunction during treatment and follow-up. Keywords: unilateral complete dysfunction of the diaphragm, unilateral partial dysfunction of the diaphragm, positional changes, ΔVC, ΔFVC, fractional thickening of the diaphragm.
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
The Choice of an Inhalation Device Based on Peak Inspiratory Flow Value in Patients with Bronchial Asthma
Aim. To determine the value of peak inspiratory flow (PIF) in patients depending on the level of control and the period of bronchial asthma (BA) in order to choose the preferred inhaler with an emphasis on the turbuhaler. Design. Cohort, comparative, prospective study. Materials and methods. 71 patients with BA were examined. The patients were divided into three groups: 20 patients with complete BA control, 23 patients with partial BA control, and 28 patients with exacerbation of the disease. The control group consisted of 29 healthy men. When determining the PIF, a metered aerosol inhaler and a respimat (R0, without resistance) were taken into account, as well as five levels of resistance for powder inhalers (PI), each corresponding to a specific type of inhaler: R1 — low (breezhaler, aerolizer), R2 — medium-low (ellipta), R3 — medium (turbuhaler, spiromax), R4 — medium-high (nexthaler), and R5 — high resistance (handihaler). Optimal PIF values were considered to be R0 ≥ 90 l/min, R1–R4 ≥ 60 l/min, R5 ≥ 30 l/min, with lower values being suboptimal (sPIF), and PIF 30 l/min for R1–R4 being minimal. 64 patients received formoterol/budesonide using various delivery devices, and 24 of them used the turbuhaler inhalation device. Results. The determination of PIF when simulating the resistance of an inhalation device revealed sPIF in 5–45% of patients with complete control of asthma (using a turbuhaler — 20%, in practice, sPIF was not detected). In patients with partial control of asthma, sPIF was observed in 13–56% of patients (using a turbuhaler — 35%, in practice, this figure was 80% among patients receiving formoterol/budesonide). In patients with exacerbations of BA, the limitation of PIF was observed in 11–86% of patients (in 68% of patients using the turbuhaler, and in 100% of patients taking formoterol/budesonide). Conclusion. In the case of complete control of asthma, with an imitation value of sPIF in 20% and no sPIF in practice, most patients were able to use drug delivery devices according to their preferences, provided that the inhalation technique was correct. In the case of partial control of asthma, the proportion of imitation sPIF increased. Optimization of inhalation therapy using the turbuhaler involved increasing the dose of medication. All patients with exacerbations of asthma were prescribed nebulizer therapy and metered-dose inhalers with a spacer upon admission to the hospital. The imitation limitation of PIF was observed with all types of PIs indicating the ineffectiveness of using the turbuhaler during this period of the disease. Temporary change of the PI with medium resistance of the device (turbuhaler) to the metered aerosol inhaler (rapihaler with spacer) with zero resistance, it allows for a personalized approach to choosing an inhaler at the time of hospitalization for patients with exacerbated BA, upon discharge, and by the 30th day of follow-up. Keywords: bronchial asthma, inhaler, turbuhaler, rapihaler, peak inspiratory flow
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessThe Choice of an Inhalation Device Based on Peak Inspiratory Flow Value in Patients with Bronchial Asthma
Aim. To determine the value of peak inspiratory flow (PIF) in patients depending on the level of control and the period of bronchial asthma (BA) in order to choose the preferred inhaler with an emphasis on the turbuhaler. Design. Cohort, comparative, prospective study. Materials and methods. 71 patients with BA were examined. The patients were divided into three groups: 20 patients with complete BA control, 23 patients with partial BA control, and 28 patients with exacerbation of the disease. The control group consisted of 29 healthy men. When determining the PIF, a metered aerosol inhaler and a respimat (R0, without resistance) were taken into account, as well as five levels of resistance for powder inhalers (PI), each corresponding to a specific type of inhaler: R1 — low (breezhaler, aerolizer), R2 — medium-low (ellipta), R3 — medium (turbuhaler, spiromax), R4 — medium-high (nexthaler), and R5 — high resistance (handihaler). Optimal PIF values were considered to be R0 ≥ 90 l/min, R1–R4 ≥ 60 l/min, R5 ≥ 30 l/min, with lower values being suboptimal (sPIF), and PIF 30 l/min for R1–R4 being minimal. 64 patients received formoterol/budesonide using various delivery devices, and 24 of them used the turbuhaler inhalation device. Results. The determination of PIF when simulating the resistance of an inhalation device revealed sPIF in 5–45% of patients with complete control of asthma (using a turbuhaler — 20%, in practice, sPIF was not detected). In patients with partial control of asthma, sPIF was observed in 13–56% of patients (using a turbuhaler — 35%, in practice, this figure was 80% among patients receiving formoterol/budesonide). In patients with exacerbations of BA, the limitation of PIF was observed in 11–86% of patients (in 68% of patients using the turbuhaler, and in 100% of patients taking formoterol/budesonide). Conclusion. In the case of complete control of asthma, with an imitation value of sPIF in 20% and no sPIF in practice, most patients were able to use drug delivery devices according to their preferences, provided that the inhalation technique was correct. In the case of partial control of asthma, the proportion of imitation sPIF increased. Optimization of inhalation therapy using the turbuhaler involved increasing the dose of medication. All patients with exacerbations of asthma were prescribed nebulizer therapy and metered-dose inhalers with a spacer upon admission to the hospital. The imitation limitation of PIF was observed with all types of PIs indicating the ineffectiveness of using the turbuhaler during this period of the disease. Temporary change of the PI with medium resistance of the device (turbuhaler) to the metered aerosol inhaler (rapihaler with spacer) with zero resistance, it allows for a personalized approach to choosing an inhaler at the time of hospitalization for patients with exacerbated BA, upon discharge, and by the 30th day of follow-up. Keywords: bronchial asthma, inhaler, turbuhaler, rapihaler, peak inspiratory flow
- 13 April 2023
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 25 (1) , 145-154
Associations of polymorphisms of the ACE and ACE2 genes with clinical manifestations and cardiovascular complications of the coronavirus infection
A problem of the novel coronavirus infection pandemic is the absence of specific biomarkers, the determination of which would make it possible to assess the likelihood of a severe disease course, development of complications, immediate and long-term consequences, and effective etiotropic (antiviral) therapy. The severity of the novel coronavirus infection depends on various factors such as the initial state of health, immune status, age, smoking status, concomitant cardiovascular diseases, and diabetes mellitus. However, a severe disease course is also observed in patients without the aforementioned risk factors. The development of the disease and its complications depends on sex and geographical identity. Angiotensin-converting enzyme 2 (ACE2), associated by gene-gene interaction with ACE, plays a main role in the pathogenesis of the penetration of severe acute respiratory syndrome-2 coronavirus into the cell. The main body of information on this problem is represented by systematic meta-analyses and results of single-center cohort studies, which offer insufficient information to unequivocally assert the associations of ACE and ACE2 gene polymorphisms with pathological changes in the circulatory system during and after a new coronavirus infection. Differences in the incidence of ACE and ACE2 alleles may explain the differences between susceptible populations and/or response to the severe coronavirus infection. The above studies were carried out on the effect of the coronavirus in the initial period of the pandemic. For a more complete molecular genetic picture of the influence of polymorphism, persons with different strains of the coronavirus must be considered. In addition, no data are available regarding the expressions of ACE and ACE2 genes in response to a coronavirus infection. Moreover, the identification of the polymorphic variants of the genes of the reninangiotensinaldosterone system and ACE2 associated with a high risk of developing and worsening cardiovascular diseases may be one of the promising areas for the early diagnosis and prevention of post-COVID-19 changes. Therefore, all scientific interest research is aimed at studying genetic factors, such as single nucleotide polymorphisms that affect susceptibility to infection, severity of the disease course, and development of circulatory system consequences. In general, polymorphic variants of ACE and ACE2 and their interaction will help us understand this problem and systematize knowledge for further research in this area.
- 13 April 2023
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 25 (1) , 145-154
Associations of polymorphisms of the ACE and ACE2 genes with clinical manifestations and cardiovascular complications of the coronavirus infection
A problem of the novel coronavirus infection pandemic is the absence of specific biomarkers, the determination of which would make it possible to assess the likelihood of a severe disease course, development of complications, immediate and long-term consequences, and effective etiotropic (antiviral) therapy. The severity of the novel coronavirus infection depends on various factors such as the initial state of health, immune status, age, smoking status, concomitant cardiovascular diseases, and diabetes mellitus. However, a severe disease course is also observed in patients without the aforementioned risk factors. The development of the disease and its complications depends on sex and geographical identity. Angiotensin-converting enzyme 2 (ACE2), associated by gene-gene interaction with ACE, plays a main role in the pathogenesis of the penetration of severe acute respiratory syndrome-2 coronavirus into the cell. The main body of information on this problem is represented by systematic meta-analyses and results of single-center cohort studies, which offer insufficient information to unequivocally assert the associations of ACE and ACE2 gene polymorphisms with pathological changes in the circulatory system during and after a new coronavirus infection. Differences in the incidence of ACE and ACE2 alleles may explain the differences between susceptible populations and/or response to the severe coronavirus infection. The above studies were carried out on the effect of the coronavirus in the initial period of the pandemic. For a more complete molecular genetic picture of the influence of polymorphism, persons with different strains of the coronavirus must be considered. In addition, no data are available regarding the expressions of ACE and ACE2 genes in response to a coronavirus infection. Moreover, the identification of the polymorphic variants of the genes of the reninangiotensinaldosterone system and ACE2 associated with a high risk of developing and worsening cardiovascular diseases may be one of the promising areas for the early diagnosis and prevention of post-COVID-19 changes. Therefore, all scientific interest research is aimed at studying genetic factors, such as single nucleotide polymorphisms that affect susceptibility to infection, severity of the disease course, and development of circulatory system consequences. In general, polymorphic variants of ACE and ACE2 and their interaction will help us understand this problem and systematize knowledge for further research in this area.